(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

YARTEMLEASSIST PATIENT SUPPORT PROGRAM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

YARTEMLEASSIST PATIENT SUPPORT PROGRAM

ST13

US500000097462726

Classe

16, 35, 36, 41

Pedido

97462726

Registro

8206166

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

49

Atualização mais recente

07/04/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

16, 35, 36, 41

Data de depósito

16/06/2022

Data de registro

07/04/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

07/04/2026

Última transação

07/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

2026-02-00

Primeiro uso no comércio

2026-02-00

Código do desenho

3

Tipo de titular

03

Localização do titular

Seattle, WA, US

Examinador

BODRI, KRISTIN MARIE

Unidade examinadora

L50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the trademark "YARTEMLEASSIST" in capital letters, with "YARTEMLEA" in white, and "SSIST" in gold, in which the second letters "E" and "A" are connected with a thick gold curving line that goes from the middle horizontal line in the "E" and crosses the middle of the letter "A" and serves as its crossbar. The second letter "A" also features a gold sloping line to the right of and paralleling the right leg of that letter. The phrase "PATIENTSUPPORT PROGRAM" is below in a parallelogram with a white border with rounded upper right and lower left corners, with the wording "PATIENT SUPPORT PROGRAM" in white. The color black shown in the mark is meant to represent transparent area only and is not claimed as a feature of the mark.

Titulares e representantes

Titulares

O. C. (pessoa física)

Representantes

Kelley B. Harrington Cooley LLP

Classificação técnica

Classes Nice

Classe 16Classe 35Classe 36Classe 41

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 16

Printed publications in the nature of brochurespamphletsnewsletterswritten articles and guidebooks in the field of medical information and patient support

Classe 35

Promoting awareness of patient support offerings for endothelial diseases and disordersrenal diseasestransplant complicationsischemia-reperfusion injury and hematologicalautoimmuneneurologicalimmunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disordersrenal diseasestransplant complicationshematologicalneurologicalimmunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals

Classe 36

Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance servicesbenefits verification in the nature of insurance claims administration; and providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disordersrenal diseasestransplant complicationshematologicalneurologicalimmunological and inflammation-related disease and disorders

Classe 41

Educational servicesconducting educational programs in the fields of endothelial diseases and disordersrenal diseasestransplant complicationshematologicalneurologicalimmunological and inflammation-related disease and disorders and treatment and patient support options for these conditions

Publicações

Histórico de despachos e eventos da marca no USPTO.

49 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/04/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/04/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

13/03/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

13/03/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

13/03/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/03/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

13/03/2026

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

13/03/2026

DMCC

DATA MODIFICATION COMPLETED

02/03/2026

ALIE

ASSIGNED TO LIE

24/02/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

19/02/2026

IUAF

USE AMENDMENT FILED

11/02/2026

EISU

TEAS STATEMENT OF USE RECEIVED

11/02/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

18/12/2025

EX5G

SOU EXTENSION 5 GRANTED

18/12/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

18/12/2025

EXT5

SOU EXTENSION 5 FILED

29/07/2025

EEXT

SOU TEAS EXTENSION RECEIVED

29/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/03/2025

EX4G

SOU EXTENSION 4 GRANTED

16/01/2025

EXT4

SOU EXTENSION 4 FILED

16/01/2025

EEXT

SOU TEAS EXTENSION RECEIVED

16/01/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

14/11/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/11/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

14/11/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

14/11/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

21/06/2024

EX3G

SOU EXTENSION 3 GRANTED

21/06/2024

EXT3

SOU EXTENSION 3 FILED

21/06/2024

EEXT

SOU TEAS EXTENSION RECEIVED

21/06/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

26/01/2024

EX2G

SOU EXTENSION 2 GRANTED

24/01/2024

EXT2

SOU EXTENSION 2 FILED

24/01/2024

EEXT

SOU TEAS EXTENSION RECEIVED

24/01/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/07/2023

EX1G

SOU EXTENSION 1 GRANTED

10/07/2023

EXT1

SOU EXTENSION 1 FILED

10/07/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/07/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

14/02/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/12/2022

PUBO

PUBLISHED FOR OPPOSITION

20/12/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

30/11/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/11/2022

DOCK

ASSIGNED TO EXAMINER

08/11/2022

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/07/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/07/2022

NWAP

NEW APPLICATION ENTERED

20/06/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace YARTEMLEASSIST PATIENT SUPPORT PROGRAM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.